India Glycols（500201）株式概要グリーン石油化学会社であるインディア・グリコール社は、インドで工業用化学品の製造・販売を行っている。 詳細500201 ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績5/6財務の健全性2/6配当金2/6報酬株価収益率（ 22 x） Indian市場（ 23.2 x）を下回っています。過去1年間で収益は26.8%増加しました リスク分析利払いは収益で十分にカバーされない 0.78%の配当はフリーキャッシュフローで十分にカバーされていない すべてのリスクチェックを見る500201 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹960.5067.0% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-568m69b2016201920222025202620282031Revenue ₹68.7bEarnings ₹4.8bAdvancedSet Fair ValueView all narrativesIndia Glycols Limited 競合他社Kingfa Science & Technology (India)Symbol: BSE:524019Market cap: ₹70.4bResponsive IndustriesSymbol: BSE:505509Market cap: ₹45.9bEpigralSymbol: NSEI:EPIGRALMarket cap: ₹49.6bKAMA HoldingsSymbol: BSE:532468Market cap: ₹81.9b価格と性能株価の高値、安値、推移の概要India Glycols過去の株価現在の株価₹960.5052週高値₹1,222.8552週安値₹793.95ベータ0.251ヶ月の変化-13.54%3ヶ月変化9.50%1年変化4.83%3年間の変化211.12%5年間の変化254.13%IPOからの変化1,774.15%最新ニュースNew Risk • May 16New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.0% net profit margin).Reported Earnings • May 16Full year 2026 earnings released: EPS: ₹45.95 (vs ₹37.29 in FY 2025)Full year 2026 results: EPS: ₹45.95 (up from ₹37.29 in FY 2025). Revenue: ₹98.3b (up 161% from FY 2025). Net income: ₹2.93b (up 27% from FY 2025). Profit margin: 3.0% (down from 6.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹10.79 (vs ₹9.18 in 3Q 2025)Third quarter 2026 results: EPS: ₹10.79 (up from ₹9.18 in 3Q 2025). Revenue: ₹25.5b (up 162% from 3Q 2025). Net income: ₹675.7m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 5.8% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 25India Glycols Limited announced that it has received INR 4.669944975 billion in funding from a group of investorsOn November 24, 2025, India Glycols Limited closed the transaction.Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹10.51 (vs ₹8.03 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.51 (up from ₹8.03 in 2Q 2025). Revenue: ₹24.1b (up 151% from 2Q 2025). Net income: ₹650.6m (up 31% from 2Q 2025). Profit margin: 2.7% (down from 5.2% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 38% per year.お知らせ • Oct 17India Glycols Limited announced that it expects to receive INR 4.669944975 billion in funding from Kashipur Holdings Limited, 360 ONE Portfolio Managers Limited, QRG Investments and Holdings Limited, Rose Farms (Delhi) Private LimitedIndia Glycols Limited announces that it has announced a private placement with Kashipur Holdings Limited, 360 One Pipe Fund and others to issue 5,103,765 Equity Shares at a price of INR 915 per share for gross proceeds of INR 4,669,944,975 on October 16, 2025.最新情報をもっと見るRecent updatesNew Risk • May 16New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.0% net profit margin).Reported Earnings • May 16Full year 2026 earnings released: EPS: ₹45.95 (vs ₹37.29 in FY 2025)Full year 2026 results: EPS: ₹45.95 (up from ₹37.29 in FY 2025). Revenue: ₹98.3b (up 161% from FY 2025). Net income: ₹2.93b (up 27% from FY 2025). Profit margin: 3.0% (down from 6.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹10.79 (vs ₹9.18 in 3Q 2025)Third quarter 2026 results: EPS: ₹10.79 (up from ₹9.18 in 3Q 2025). Revenue: ₹25.5b (up 162% from 3Q 2025). Net income: ₹675.7m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 5.8% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 25India Glycols Limited announced that it has received INR 4.669944975 billion in funding from a group of investorsOn November 24, 2025, India Glycols Limited closed the transaction.Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹10.51 (vs ₹8.03 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.51 (up from ₹8.03 in 2Q 2025). Revenue: ₹24.1b (up 151% from 2Q 2025). Net income: ₹650.6m (up 31% from 2Q 2025). Profit margin: 2.7% (down from 5.2% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 38% per year.お知らせ • Oct 17India Glycols Limited announced that it expects to receive INR 4.669944975 billion in funding from Kashipur Holdings Limited, 360 ONE Portfolio Managers Limited, QRG Investments and Holdings Limited, Rose Farms (Delhi) Private LimitedIndia Glycols Limited announces that it has announced a private placement with Kashipur Holdings Limited, 360 One Pipe Fund and others to issue 5,103,765 Equity Shares at a price of INR 915 per share for gross proceeds of INR 4,669,944,975 on October 16, 2025.Upcoming Dividend • Sep 16Upcoming dividend of ₹10.00 per shareEligible shareholders must have bought the stock before 23 September 2025. Payment date: 30 October 2025. Payout ratio is a comfortable 13% but the company is not cash flow positive. Trailing yield: 1.2%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).お知らせ • Sep 05India Glycols Limited announces Annual dividend, payable on October 30, 2025India Glycols Limited announced Annual dividend of INR 10.0000 per share payable on October 30, 2025, ex-date on September 23, 2025 and record date on September 23, 2025.お知らせ • Sep 04+ 3 more updatesIndia Glycols Limited to Report First Half, 2026 Results on Feb 14, 2026India Glycols Limited announced that they will report first half, 2026 results on Feb 14, 2026お知らせ • Sep 02India Glycols Limited, Annual General Meeting, Sep 30, 2025India Glycols Limited, Annual General Meeting, Sep 30, 2025, at 11:00 Indian Standard Time.Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹23.66 (vs ₹19.50 in 1Q 2025)First quarter 2026 results: EPS: ₹23.66 (up from ₹19.50 in 1Q 2025). Revenue: ₹25.0b (up 159% from 1Q 2025). Net income: ₹732.5m (up 21% from 1Q 2025). Profit margin: 2.9% (down from 6.2% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 01India Glycols Limited to Report Q1, 2026 Results on Aug 07, 2025India Glycols Limited announced that they will report Q1, 2026 results on Aug 07, 2025Reported Earnings • May 17Full year 2025 earnings released: EPS: ₹74.58 (vs ₹55.87 in FY 2024)Full year 2025 results: EPS: ₹74.58 (up from ₹55.87 in FY 2024). Revenue: ₹90.5b (up 175% from FY 2024). Net income: ₹2.31b (up 34% from FY 2024). Profit margin: 2.6% (down from 5.3% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 13Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,642, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 69% over the past three years.お知らせ • May 10India Glycols Limited to Report Q4, 2025 Results on May 16, 2025India Glycols Limited announced that they will report Q4, 2025 results on May 16, 2025Valuation Update With 7 Day Price Move • Apr 17Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹1,427, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 45% over the past three years.Reported Earnings • Feb 05Third quarter 2025 earnings released: EPS: ₹18.35 (vs ₹13.45 in 3Q 2024)Third quarter 2025 results: EPS: ₹18.35 (up from ₹13.45 in 3Q 2024). Revenue: ₹24.3b (up 169% from 3Q 2024). Net income: ₹568.1m (up 37% from 3Q 2024). Profit margin: 2.3% (down from 4.6% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,414, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years.お知らせ • Jan 28India Glycols Limited to Report Q3, 2025 Results on Feb 04, 2025India Glycols Limited announced that they will report Q3, 2025 results on Feb 04, 2025Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,406, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.お知らせ • Dec 31India Glycols Limited Announces Resignation of Rakesh Kumar, Chief Human Resource OfficerIndia Glycols Limited informed that Mr. Rakesh Kumar, Chief Human Resource Officer (CHRO), a senior management person, has tendered his resignation. The Company has accepted his resignation with effect from the closure of business hours on 31 December 2024.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹1,360, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 61% over the past three years.Reported Earnings • Nov 08Second quarter 2025 earnings released: EPS: ₹16.06 (vs ₹12.27 in 2Q 2024)Second quarter 2025 results: EPS: ₹16.06 (up from ₹12.27 in 2Q 2024). Revenue: ₹21.5b (up 177% from 2Q 2024). Net income: ₹497.1m (up 31% from 2Q 2024). Profit margin: 2.3% (down from 4.9% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.お知らせ • Oct 31India Glycols Limited to Report Q2, 2025 Results on Nov 07, 2024India Glycols Limited announced that they will report Q2, 2025 results on Nov 07, 2024Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,470, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years.お知らせ • Sep 21India Glycols Limited Announces Director Changes, Effective September 30, 2024India Glycols Limited approved the cessation of Mr. Pradip Kumar Khaitan, Mr. Jagmohan N. Kejriwal, Mr. Ravi Jhunjhunwala, and Mr. Jitender Balakrishnan as Independent Directors of the company upon the completion of their second term, with effect from the close of business hours on 30th September 2024.お知らせ • Aug 28India Glycols Limited Approves Dividend for the Financial Year Ended 31 March 2024India Glycols Limited announced that at its AGM held on 28 August 2024, the shareholders approved dividend of INR 8 per equity share for the financial year ended 31 March 2024.Upcoming Dividend • Aug 14Upcoming dividend of ₹8.00 per shareEligible shareholders must have bought the stock before 21 August 2024. Payment date: 27 September 2024. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.1%). In line with average of industry peers (0.7%).お知らせ • Jul 30India Glycols Limited, Annual General Meeting, Aug 28, 2024India Glycols Limited, Annual General Meeting, Aug 28, 2024, at 11:00 Indian Standard Time.Reported Earnings • Jul 30First quarter 2025 earnings released: EPS: ₹19.50 (vs ₹16.52 in 1Q 2024)First quarter 2025 results: EPS: ₹19.50 (up from ₹16.52 in 1Q 2024). Revenue: ₹22.9b (up 232% from 1Q 2024). Net income: ₹603.8m (up 18% from 1Q 2024). Profit margin: 2.6% (down from 7.4% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,176, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 75% over the past three years.お知らせ • Jul 22India Glycols Limited to Report Q1, 2025 Results on Jul 29, 2024India Glycols Limited announced that they will report Q1, 2025 results at 3:30 PM, Indian Standard Time on Jul 29, 2024Valuation Update With 7 Day Price Move • Jun 07Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹870, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 63% over the past three years.お知らせ • May 30India Glycols Limited Recommends Dividend for the Financial Year Ended 31St March, 2024Board of Directors of India Glycols Limited in its meeting held on 28th May, 2024 has, inter-alia, considered and approved Recommended a dividend of INR 8/- per equity share (@ 80%) of face value of INR 10/- each for the financial year ended 31st March, 2024 which, if confirmed/declared by the members at the upcoming Annual General Meeting ("AGM"), will be paid/dispatched within 30 days from the date of AGM.Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹55.87 (vs ₹40.40 in FY 2023)Full year 2024 results: EPS: ₹55.87 (up from ₹40.40 in FY 2023). Revenue: ₹79.5b (up 200% from FY 2023). Net income: ₹1.73b (up 38% from FY 2023). Profit margin: 2.2% (down from 4.7% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.お知らせ • May 23India Glycols Limited to Report Q4, 2024 Results on May 28, 2024India Glycols Limited announced that they will report Q4, 2024 results on May 28, 2024Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹870, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years.Reported Earnings • Feb 03Third quarter 2024 earnings released: EPS: ₹13.45 (vs ₹16.16 in 3Q 2023)Third quarter 2024 results: EPS: ₹13.45 (down from ₹16.16 in 3Q 2023). Revenue: ₹21.2b (up 284% from 3Q 2023). Net income: ₹416.3m (down 17% from 3Q 2023). Profit margin: 2.0% (down from 9.0% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.お知らせ • Jan 26India Glycols Limited to Report Q3, 2024 Results on Feb 02, 2024India Glycols Limited announced that they will report Q3, 2024 results on Feb 02, 2024Reported Earnings • Nov 04Second quarter 2024 earnings released: EPS: ₹12.27 (vs ₹7.62 in 2Q 2023)Second quarter 2024 results: EPS: ₹12.27 (up from ₹7.62 in 2Q 2023). Revenue: ₹18.8b (up 181% from 2Q 2023). Net income: ₹380.1m (up 61% from 2Q 2023). Profit margin: 2.0% (down from 3.5% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 04India Glycols Limited Appoints Shri Vishal Shishodia as Head - Imfl (Sales & Marketing)India Glycols Limited announced appointment of Shri Vishal Shishodia as Head - IMFL (Sales & Marketing) in the category of Senior Management Personnel, on recommendation of the Nomination & Remuneration Committee, of the Company with effect from 3 November, 2023.お知らせ • Oct 28India Glycols Limited to Report Q2, 2023 Results on Nov 03, 2023India Glycols Limited announced that they will report Q2, 2023 results on Nov 03, 2023お知らせ • Sep 13India Glycols Limited Announces Cessation of Tejinder Paul Sharma as Head IMFL (Sales & Marketing)India Glycols Limited announced that Mr. Tejinder Paul Sharma, Head IMFL (Sales & Marketing) ceases to be a Senior Management Person of the Company on attaining superannuation with effect from close of business hours of 12th September, 2023.Upcoming Dividend • Aug 29Upcoming dividend of ₹7.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 05 September 2023. Payment date: 12 October 2023. Payout ratio is a comfortable 19% but the company is not cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%).お知らせ • Aug 18+ 1 more updateIndia Glycols Limited Announces Resignation of Dipankar Mukherjee as Head - Technical ServicesIndia Glycols Limited announced that Mr. Dipankar Mukherjee, Head - Technical Services, a senior management person, has tendered his resignation on account of personal reasons. The Company has accepted his resignation and relieved him from the service w.e.f. 12th August, 2023.Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹733, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 163% over the past three years.Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: ₹16.52 (vs ₹8.91 in 1Q 2023)First quarter 2024 results: EPS: ₹16.52 (up from ₹8.91 in 1Q 2023). Revenue: ₹19.0b (up 135% from 1Q 2023). Net income: ₹511.4m (up 76% from 1Q 2023). Profit margin: 2.7% (down from 3.6% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 01India Glycols Limited to Report Q1, 2024 Results on Aug 07, 2023India Glycols Limited announced that they will report Q1, 2024 results on Aug 07, 2023Board Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 7 highly experienced directors. Additional Whole Time Director Pragya Barwale was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • May 25Full year 2023 earnings released: EPS: ₹45.55 (vs ₹106 in FY 2022)Full year 2023 results: EPS: ₹45.55 (down from ₹106 in FY 2022). Revenue: ₹66.7b (up 132% from FY 2022). Net income: ₹1.25b (down 62% from FY 2022). Profit margin: 1.9% (down from 12% in FY 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 25India Glycols Limited Recommends Dividend for the Financial Year Ended 31 March, 2023India Glycols Limited Recommended a dividend of INR 7.50/- per equity share (@75%) of face value of INR 10/- each for the financial year ended 31st March, 2023 which, if confirmed/declared by the members at the ensuing Annual General Meeting ("AGM"), will be paid/dispatched within 30 days from the date of AGM.お知らせ • May 19India Glycols Limited to Report Q4, 2023 Results on May 24, 2023India Glycols Limited announced that they will report Q4, 2023 results on May 24, 2023Reported Earnings • Feb 10Third quarter 2023 earnings released: EPS: ₹16.16 (vs ₹7.75 in 3Q 2022)Third quarter 2023 results: EPS: ₹16.16 (up from ₹7.75 in 3Q 2022). Revenue: ₹5.54b (down 30% from 3Q 2022). Net income: ₹500.3m (up 108% from 3Q 2022). Profit margin: 9.0% (up from 3.0% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 27% per year.お知らせ • Feb 02India Glycols Limited to Report Q3, 2023 Results on Feb 08, 2023India Glycols Limited announced that they will report Q3, 2023 results on Feb 08, 2023お知らせ • Dec 24Gateway Distriparks Limited (NSEI:GATEWAY) completed the acquisition of 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited.Gateway Distriparks Limited (NSEI:GATEWAY) signed the Share Purchase Agreement to acquire 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited for INR 1.6 billion on October 31, 2022. The purchase consideration is payable in cash, which is subject to certain preclosing and post-closing adjustments in accordance with the terms of the SPA. India Glycols holds 42.31% stake and its nominee(s) and affiliate holds 6.61% in Kashipur Infrastructure. The process to acquire the remaining 0.08% shareholding from Fourcee Infrastructure Equipments Private Limited (in liquidation) has been initiated at the same per share price as finally paid for acquisition of the 99.92% shareholding. KIFTPL has earned a revenue of approximately INR 275.5 million and net worth of INR 677.6 million in FY 2021-22. The proposed transaction is subject to customary approvals, and other conditions precedent required to be fulfilled by KIFTPL and / or the Sellers. Board of Directors of India Glycols and Gateway Distriparks approved the Kashipur Infrastructure transaction. The transaction is expected within third quarter of FY 2022-23. Prasenjit Chakravarti, and Nitish Goel of Khaitan & Co acted as advisor to GDL In Its Acquisition Of Kashipur Infrastructure Gateway Distriparks Limited (NSEI:GATEWAY) completed the acquisition of 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited on December 23, 2022.Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹7.62 (vs ₹12.04 in 2Q 2022)Second quarter 2023 results: EPS: ₹7.62 (down from ₹12.04 in 2Q 2022). Revenue: ₹6.70b (down 14% from 2Q 2022). Net income: ₹235.8m (down 37% from 2Q 2022). Profit margin: 3.5% (down from 4.8% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹7.62 (vs ₹12.04 in 2Q 2022)Second quarter 2023 results: EPS: ₹7.62 (down from ₹12.04 in 2Q 2022). Revenue: ₹16.4b (up 110% from 2Q 2022). Net income: ₹235.8m (down 37% from 2Q 2022). Profit margin: 1.4% (down from 4.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 04India Glycols Limited to Report Q2, 2023 Results on Nov 10, 2022India Glycols Limited announced that they will report Q2, 2023 results on Nov 10, 2022お知らせ • Nov 02Gateway Distriparks Limited (NSEI:GATEWAY) signed the Share Purchase Agreement to acquire 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited for INR 1.6 billion.Gateway Distriparks Limited (NSEI:GATEWAY) signed the Share Purchase Agreement to acquire 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited for INR 1.6 billion on October 31, 2022. The purchase consideration is payable in cash, which is subject to certain preclosing and post-closing adjustments in accordance with the terms of the SPA. India Glycols holds 42.31% stake and its nominee(s) and affiliate holds 6.61% in Kashipur Infrastructure. The process to acquire the remaining 0.08% shareholding from Fourcee Infrastructure Equipments Private Limited (in liquidation) has been initiated at the same per share price as finally paid for acquisition of the 99.92% shareholding. KIFTPL has earned a revenue of approximately INR 275.5 million and net worth of INR 677.6 million in FY 2021-22. The proposed transaction is subject to customary approvals, and other conditions precedent required to be fulfilled by KIFTPL and / or the Sellers. Board of Directors of India Glycols and Gateway Distriparks approved the Kashipur Infrastructure transaction. The transaction is expected within third quarter of FY 2022-23. Prasenjit Chakravarti, and Nitish Goel of Khaitan & Co acted as advisor to GDL In Its Acquisition Of Kashipur Infrastructureお知らせ • Sep 08India Glycols Limited Declares Dividend for the Financial Year 2021-22India Glycols Limited at it's AGM approved dividend of INR 7.50 per Equity share for the financial year 2021-22.Upcoming Dividend • Aug 22Upcoming dividend of ₹7.50 per shareEligible shareholders must have bought the stock before 29 August 2022. Payment date: 07 October 2022. Payout ratio is a comfortable 15% but the company is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.7%).お知らせ • Aug 13India Glycols Limited, Annual General Meeting, Sep 07, 2022India Glycols Limited, Annual General Meeting, Sep 07, 2022, at 11:00 Indian Standard Time. Agenda: To receive, consider and adopt the audited financial statements (including the consolidated financial statements) of the Company for the financial year ended 31st March, 2022, together with the Reports of the Board of Directors and Auditors thereon;to declare dividend of INR 7.50/- per Equity share for the financial year 2021-22;to appoint a Director in place of Shri Sudhir Agarwal (DIN: 08602216), who retires by rotation and being eligible, offers himself for re-appointment;and to consider other matters.Reported Earnings • Aug 11First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: ₹8.14b (up 25% from 1Q 2022). Net income: ₹290.2m (down 86% from 1Q 2022). Profit margin: 3.6% (down from 31% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 53% per year whereas the company’s share price has increased by 56% per year.お知らせ • Aug 03India Glycols Limited to Report Q1, 2023 Results on Aug 09, 2022India Glycols Limited announced that they will report Q1, 2023 results on Aug 09, 2022Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹106 (vs ₹35.27 in FY 2021)Full year 2022 results: EPS: ₹106 (up from ₹35.27 in FY 2021). Revenue: ₹28.7b (up 24% from FY 2021). Net income: ₹3.30b (up 202% from FY 2021). Profit margin: 12% (up from 4.7% in FY 2021). Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 49% per year.お知らせ • May 27India Glycols Limited Recommends Dividend for the Financial Year Ended March 31, 2022India Glycols Limited at its board meeting held on May 26, 2022 recommended a dividend of INR 7.50 per equity share (@75%) of face value of INR 10 each for the financial year ended March 31, 2022 which, if confirmed/declared by the members at the upcoming Annual General Meeting, will be paid/dispatched within 30 days from the date of AGM.お知らせ • May 20India Glycols Limited to Report Q4, 2022 Results on May 26, 2022India Glycols Limited announced that they will report Q4, 2022 results on May 26, 2022Valuation Update With 7 Day Price Move • May 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹1,018, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 342% over the past three years.Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹1,126, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 335% over the past three years.Reported Earnings • Feb 14Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹7.75 (down from ₹9.62 in 3Q 2021). Revenue: ₹17.7b (up 97% from 3Q 2021). Net income: ₹240.1m (down 20% from 3Q 2021). Profit margin: 1.4% (down from 3.3% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 05India Glycols Limited to Report Q3, 2022 Results on Feb 11, 2022India Glycols Limited announced that they will report Q3, 2022 results on Feb 11, 2022Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹926, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 218% over the past three years.Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹762, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 113% over the past three years.Reported Earnings • Aug 11First quarter 2022 earnings released: EPS ₹64.99 (vs ₹1.38 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹6.51b (up 69% from 1Q 2021). Net income: ₹2.01b (up ₹1.97b from 1Q 2021). Profit margin: 31% (up from 1.1% in 1Q 2021).Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improved over the past weekAfter last week's 39% share price gain to ₹747, the stock trades at a trailing P/E ratio of 21.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 88% over the past three years.Reported Earnings • Jun 27Full year 2021 earnings released: EPS ₹35.27 (vs ₹37.03 in FY 2020)The company reported a mediocre full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹54.4b (up 56% from FY 2020). Net income: ₹1.09b (down 4.8% from FY 2020). Profit margin: 2.0% (down from 3.3% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹551, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 28% over the past three years.Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹492, the stock trades at a trailing P/E ratio of 19.4x, down from the previous P/E ratio of 23.1x. Average P/E is 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 9.2%.Is New 90 Day High Low • Feb 25New 90-day high: ₹499The company is up 69% from its price of ₹295 on 27 November 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.お知らせ • Feb 19Clariant Chemicals Denies News on Buying Stake in India GlycolsReferring February 16, 2021 news, seeking clarification upon the recent news item which appeared on the Channel CNBC TV18 dated February 16, 2021 captioned 'Clariant Chemicals (India) Limited (BSE:506390) is planning to buy 51% stake in India Glycols Limited (BSE:500201)'. In this regard, Clariant Chemicals submit that Clariant Chemicals (India) Limited (hereinafter referred to as 'the Company') is not engaged in any discussions to acquire a stake, in India Glycols. The Company categorically states that the abovementioned news item is factually incorrect.Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹9.62 (vs ₹8.59 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹18.3b (up 112% from 3Q 2020). Net income: ₹298.2m (up 12% from 3Q 2020). Profit margin: 1.6% (down from 3.1% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.お知らせ • Feb 06India Glycols Limited to Report Q3, 2021 Results on Feb 12, 2021India Glycols Limited announced that they will report Q3, 2021 results on Feb 12, 2021Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹426, the stock is trading at a trailing P/E ratio of 17.5x, up from the previous P/E ratio of 14.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 7.4%.Is New 90 Day High Low • Feb 02New 90-day high: ₹410The company is up 52% from its price of ₹269 on 04 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹372, the stock is trading at a trailing P/E ratio of 15.3x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 19x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 30%.Is New 90 Day High Low • Dec 30New 90-day high: ₹314The company is up 12% from its price of ₹280 on 01 October 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.お知らせ • Dec 23India Glycols Ltd. Appoints Rupark Sarswat as CEOIndia Glycols Limited announced the appointment of Shri Rupark Sarswat as Chief Executive Officer and Key Managerial Personnel of the Company, as approved by the Board of Directors of the Company at their meeting held on 6 November, 2020, is effective from 21 December, 2020.Is New 90 Day High Low • Dec 04New 90-day high: ₹299The company is up 5.0% from its price of ₹285 on 04 September 2020. The Indian market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.お知らせ • Nov 07India Glycols Limited Appoints Rupark Sarswat as CEO, Effective on or Before December 18, 2020India Glycols Limited announced that at the board meeting held on November 6, 2020, it has approved appointment of Shri Rupark Sarswat as CEO and key managerial personnel of the company, on recommendation of the nomination and remuneration committee of the company. His joining date will be informed separately, which will be on or before December 18, 2020. He brings an experience of over 25 years in the specialty chemicals domain working in various roles in Business Management, Supply Chain & Operations etc. He is currently the Managing Director at Transpek-Silox Industries Private Limited which is a part of the Silox group of Belgium.Reported Earnings • Nov 07Second quarter 2021 earnings released: EPS ₹8.58The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues were improved. Second quarter 2021 results: Revenue: ₹15.4b (up 81% from 2Q 2020). Net income: ₹265.5m (down 26% from 2Q 2020). Profit margin: 1.7% (down from 4.2% in 2Q 2020). The decrease in margin was driven by higher expenses.Is New 90 Day High Low • Nov 04New 90-day low: ₹269The company is down 1.0% from its price of ₹272 on 06 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.お知らせ • Oct 31India Glycols Limited to Report Q2, 2021 Results on Nov 06, 2020India Glycols Limited announced that they will report Q2, 2021 results on Nov 06, 2020お知らせ • Aug 07India Glycols Limited to Report Q1, 2021 Results on Aug 13, 2020India Glycols Limited announced that they will report Q1, 2021 results on Aug 13, 2020お知らせ • Jun 18India Glycols Limited to Report Q4, 2020 Results on Jun 24, 2020India Glycols Limited announced that they will report Q4, 2020 results on Jun 24, 2020株主還元500201IN ChemicalsIN 市場7D-2.3%0.3%-0.7%1Y4.8%-5.5%-4.3%株主還元を見る業界別リターン: 500201過去 1 年間で-5.5 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: 500201過去 1 年間で-4.3 % の収益を上げたIndian市場を上回りました。価格変動Is 500201's price volatile compared to industry and market?500201 volatility500201 Average Weekly Movement5.8%Chemicals Industry Average Movement7.3%Market Average Movement7.2%10% most volatile stocks in IN Market10.2%10% least volatile stocks in IN Market4.7%安定した株価: 500201 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 500201の 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19831,357Rupark Sarswatwww.indiaglycols.comグリーン石油化学会社であるIndia Glycols Limitedは、インドで工業用化学品の製造・販売を行っている。バイオベースのスペシャリティーズとパフォーマンスケミカルズ、ポタブルスピリッツ、エナチュア・バイオファーマの各セグメントで事業を展開。バイオモノエチレン、ジエチレン、トリエチレングリコール、エチル/ブチルグリコールエーテル、アセテート、ブレーキ液、グアーガムや天然ガムからなるバイオポリマー、バイオ燃料、可塑剤、油田用化学品、バイオアミン、大豆酸メチル、MDEA、MDEA誘導体、バイオポタシュ顆粒、C-Smart特殊製品などの特殊化学品を提供している；糖蜜と穀物ベースの超中性アルコール、工業用・医療用酸素、食品用・工業用二酸化炭素、液体アルゴン・窒素、酸化エチレン、酸化バイオエチレンなどの特殊ガス。また、Soulmate BluやSingle Reserveブランドのウイスキー、Amazingブランドのウォッカ、ZumbaやBeach House XXXブランドのラム酒、Buntyブランドのエコノミー・スピリッツ、カントリーブランドの酒など、インド製の外国産酒類も提供している。さらに、天然活性医薬品成分、栄養補助食品、標準化植物エキス、ニコチン誘導体も提供している。さらに、同社の製品は、医薬品・ヘルスケア、繊維、自動車、パーソナルケア、工業・製造、塗料・コーティング、石油・ガス、食品原料、包装、飲料用蒸留酒、その他様々な産業で利用されている。また、製品の輸出も行っている。前身はUP Glycols Limitedで、1986年8月にIndia Glycols Limitedに社名変更。インディア・グリコール社は1983年に設立され、本社はインドのノイダにある。もっと見るIndia Glycols Limited 基礎のまとめIndia Glycols の収益と売上を時価総額と比較するとどうか。500201 基礎統計学時価総額₹65.54b収益（TTM）₹2.93b売上高(TTM)₹42.11b22.0xPER（株価収益率1.5xP/Sレシオ500201 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計500201 損益計算書（TTM）収益₹42.11b売上原価₹30.63b売上総利益₹11.49bその他の費用₹8.56b収益₹2.93b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）43.68グロス・マージン27.28%純利益率6.95%有利子負債／自己資本比率53.8%500201 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.8%現在の配当利回り13%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/10 11:39終値2026/06/10 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋India Glycols Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Kameswari V. S. ChavaliFirstCall Research
New Risk • May 16New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.0% net profit margin).
Reported Earnings • May 16Full year 2026 earnings released: EPS: ₹45.95 (vs ₹37.29 in FY 2025)Full year 2026 results: EPS: ₹45.95 (up from ₹37.29 in FY 2025). Revenue: ₹98.3b (up 161% from FY 2025). Net income: ₹2.93b (up 27% from FY 2025). Profit margin: 3.0% (down from 6.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹10.79 (vs ₹9.18 in 3Q 2025)Third quarter 2026 results: EPS: ₹10.79 (up from ₹9.18 in 3Q 2025). Revenue: ₹25.5b (up 162% from 3Q 2025). Net income: ₹675.7m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 5.8% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 25India Glycols Limited announced that it has received INR 4.669944975 billion in funding from a group of investorsOn November 24, 2025, India Glycols Limited closed the transaction.
Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹10.51 (vs ₹8.03 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.51 (up from ₹8.03 in 2Q 2025). Revenue: ₹24.1b (up 151% from 2Q 2025). Net income: ₹650.6m (up 31% from 2Q 2025). Profit margin: 2.7% (down from 5.2% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 38% per year.
お知らせ • Oct 17India Glycols Limited announced that it expects to receive INR 4.669944975 billion in funding from Kashipur Holdings Limited, 360 ONE Portfolio Managers Limited, QRG Investments and Holdings Limited, Rose Farms (Delhi) Private LimitedIndia Glycols Limited announces that it has announced a private placement with Kashipur Holdings Limited, 360 One Pipe Fund and others to issue 5,103,765 Equity Shares at a price of INR 915 per share for gross proceeds of INR 4,669,944,975 on October 16, 2025.
New Risk • May 16New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (3.0% net profit margin).
Reported Earnings • May 16Full year 2026 earnings released: EPS: ₹45.95 (vs ₹37.29 in FY 2025)Full year 2026 results: EPS: ₹45.95 (up from ₹37.29 in FY 2025). Revenue: ₹98.3b (up 161% from FY 2025). Net income: ₹2.93b (up 27% from FY 2025). Profit margin: 3.0% (down from 6.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹10.79 (vs ₹9.18 in 3Q 2025)Third quarter 2026 results: EPS: ₹10.79 (up from ₹9.18 in 3Q 2025). Revenue: ₹25.5b (up 162% from 3Q 2025). Net income: ₹675.7m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 5.8% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 25India Glycols Limited announced that it has received INR 4.669944975 billion in funding from a group of investorsOn November 24, 2025, India Glycols Limited closed the transaction.
Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹10.51 (vs ₹8.03 in 2Q 2025)Second quarter 2026 results: EPS: ₹10.51 (up from ₹8.03 in 2Q 2025). Revenue: ₹24.1b (up 151% from 2Q 2025). Net income: ₹650.6m (up 31% from 2Q 2025). Profit margin: 2.7% (down from 5.2% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 38% per year.
お知らせ • Oct 17India Glycols Limited announced that it expects to receive INR 4.669944975 billion in funding from Kashipur Holdings Limited, 360 ONE Portfolio Managers Limited, QRG Investments and Holdings Limited, Rose Farms (Delhi) Private LimitedIndia Glycols Limited announces that it has announced a private placement with Kashipur Holdings Limited, 360 One Pipe Fund and others to issue 5,103,765 Equity Shares at a price of INR 915 per share for gross proceeds of INR 4,669,944,975 on October 16, 2025.
Upcoming Dividend • Sep 16Upcoming dividend of ₹10.00 per shareEligible shareholders must have bought the stock before 23 September 2025. Payment date: 30 October 2025. Payout ratio is a comfortable 13% but the company is not cash flow positive. Trailing yield: 1.2%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).
お知らせ • Sep 05India Glycols Limited announces Annual dividend, payable on October 30, 2025India Glycols Limited announced Annual dividend of INR 10.0000 per share payable on October 30, 2025, ex-date on September 23, 2025 and record date on September 23, 2025.
お知らせ • Sep 04+ 3 more updatesIndia Glycols Limited to Report First Half, 2026 Results on Feb 14, 2026India Glycols Limited announced that they will report first half, 2026 results on Feb 14, 2026
お知らせ • Sep 02India Glycols Limited, Annual General Meeting, Sep 30, 2025India Glycols Limited, Annual General Meeting, Sep 30, 2025, at 11:00 Indian Standard Time.
Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹23.66 (vs ₹19.50 in 1Q 2025)First quarter 2026 results: EPS: ₹23.66 (up from ₹19.50 in 1Q 2025). Revenue: ₹25.0b (up 159% from 1Q 2025). Net income: ₹732.5m (up 21% from 1Q 2025). Profit margin: 2.9% (down from 6.2% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 01India Glycols Limited to Report Q1, 2026 Results on Aug 07, 2025India Glycols Limited announced that they will report Q1, 2026 results on Aug 07, 2025
Reported Earnings • May 17Full year 2025 earnings released: EPS: ₹74.58 (vs ₹55.87 in FY 2024)Full year 2025 results: EPS: ₹74.58 (up from ₹55.87 in FY 2024). Revenue: ₹90.5b (up 175% from FY 2024). Net income: ₹2.31b (up 34% from FY 2024). Profit margin: 2.6% (down from 5.3% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 13Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,642, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 69% over the past three years.
お知らせ • May 10India Glycols Limited to Report Q4, 2025 Results on May 16, 2025India Glycols Limited announced that they will report Q4, 2025 results on May 16, 2025
Valuation Update With 7 Day Price Move • Apr 17Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹1,427, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 45% over the past three years.
Reported Earnings • Feb 05Third quarter 2025 earnings released: EPS: ₹18.35 (vs ₹13.45 in 3Q 2024)Third quarter 2025 results: EPS: ₹18.35 (up from ₹13.45 in 3Q 2024). Revenue: ₹24.3b (up 169% from 3Q 2024). Net income: ₹568.1m (up 37% from 3Q 2024). Profit margin: 2.3% (down from 4.6% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,414, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years.
お知らせ • Jan 28India Glycols Limited to Report Q3, 2025 Results on Feb 04, 2025India Glycols Limited announced that they will report Q3, 2025 results on Feb 04, 2025
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹1,406, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years.
お知らせ • Dec 31India Glycols Limited Announces Resignation of Rakesh Kumar, Chief Human Resource OfficerIndia Glycols Limited informed that Mr. Rakesh Kumar, Chief Human Resource Officer (CHRO), a senior management person, has tendered his resignation. The Company has accepted his resignation with effect from the closure of business hours on 31 December 2024.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹1,360, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 61% over the past three years.
Reported Earnings • Nov 08Second quarter 2025 earnings released: EPS: ₹16.06 (vs ₹12.27 in 2Q 2024)Second quarter 2025 results: EPS: ₹16.06 (up from ₹12.27 in 2Q 2024). Revenue: ₹21.5b (up 177% from 2Q 2024). Net income: ₹497.1m (up 31% from 2Q 2024). Profit margin: 2.3% (down from 4.9% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
お知らせ • Oct 31India Glycols Limited to Report Q2, 2025 Results on Nov 07, 2024India Glycols Limited announced that they will report Q2, 2025 results on Nov 07, 2024
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,470, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years.
お知らせ • Sep 21India Glycols Limited Announces Director Changes, Effective September 30, 2024India Glycols Limited approved the cessation of Mr. Pradip Kumar Khaitan, Mr. Jagmohan N. Kejriwal, Mr. Ravi Jhunjhunwala, and Mr. Jitender Balakrishnan as Independent Directors of the company upon the completion of their second term, with effect from the close of business hours on 30th September 2024.
お知らせ • Aug 28India Glycols Limited Approves Dividend for the Financial Year Ended 31 March 2024India Glycols Limited announced that at its AGM held on 28 August 2024, the shareholders approved dividend of INR 8 per equity share for the financial year ended 31 March 2024.
Upcoming Dividend • Aug 14Upcoming dividend of ₹8.00 per shareEligible shareholders must have bought the stock before 21 August 2024. Payment date: 27 September 2024. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.1%). In line with average of industry peers (0.7%).
お知らせ • Jul 30India Glycols Limited, Annual General Meeting, Aug 28, 2024India Glycols Limited, Annual General Meeting, Aug 28, 2024, at 11:00 Indian Standard Time.
Reported Earnings • Jul 30First quarter 2025 earnings released: EPS: ₹19.50 (vs ₹16.52 in 1Q 2024)First quarter 2025 results: EPS: ₹19.50 (up from ₹16.52 in 1Q 2024). Revenue: ₹22.9b (up 232% from 1Q 2024). Net income: ₹603.8m (up 18% from 1Q 2024). Profit margin: 2.6% (down from 7.4% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,176, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 75% over the past three years.
お知らせ • Jul 22India Glycols Limited to Report Q1, 2025 Results on Jul 29, 2024India Glycols Limited announced that they will report Q1, 2025 results at 3:30 PM, Indian Standard Time on Jul 29, 2024
Valuation Update With 7 Day Price Move • Jun 07Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹870, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 63% over the past three years.
お知らせ • May 30India Glycols Limited Recommends Dividend for the Financial Year Ended 31St March, 2024Board of Directors of India Glycols Limited in its meeting held on 28th May, 2024 has, inter-alia, considered and approved Recommended a dividend of INR 8/- per equity share (@ 80%) of face value of INR 10/- each for the financial year ended 31st March, 2024 which, if confirmed/declared by the members at the upcoming Annual General Meeting ("AGM"), will be paid/dispatched within 30 days from the date of AGM.
Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹55.87 (vs ₹40.40 in FY 2023)Full year 2024 results: EPS: ₹55.87 (up from ₹40.40 in FY 2023). Revenue: ₹79.5b (up 200% from FY 2023). Net income: ₹1.73b (up 38% from FY 2023). Profit margin: 2.2% (down from 4.7% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
お知らせ • May 23India Glycols Limited to Report Q4, 2024 Results on May 28, 2024India Glycols Limited announced that they will report Q4, 2024 results on May 28, 2024
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹870, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years.
Reported Earnings • Feb 03Third quarter 2024 earnings released: EPS: ₹13.45 (vs ₹16.16 in 3Q 2023)Third quarter 2024 results: EPS: ₹13.45 (down from ₹16.16 in 3Q 2023). Revenue: ₹21.2b (up 284% from 3Q 2023). Net income: ₹416.3m (down 17% from 3Q 2023). Profit margin: 2.0% (down from 9.0% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.
お知らせ • Jan 26India Glycols Limited to Report Q3, 2024 Results on Feb 02, 2024India Glycols Limited announced that they will report Q3, 2024 results on Feb 02, 2024
Reported Earnings • Nov 04Second quarter 2024 earnings released: EPS: ₹12.27 (vs ₹7.62 in 2Q 2023)Second quarter 2024 results: EPS: ₹12.27 (up from ₹7.62 in 2Q 2023). Revenue: ₹18.8b (up 181% from 2Q 2023). Net income: ₹380.1m (up 61% from 2Q 2023). Profit margin: 2.0% (down from 3.5% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 04India Glycols Limited Appoints Shri Vishal Shishodia as Head - Imfl (Sales & Marketing)India Glycols Limited announced appointment of Shri Vishal Shishodia as Head - IMFL (Sales & Marketing) in the category of Senior Management Personnel, on recommendation of the Nomination & Remuneration Committee, of the Company with effect from 3 November, 2023.
お知らせ • Oct 28India Glycols Limited to Report Q2, 2023 Results on Nov 03, 2023India Glycols Limited announced that they will report Q2, 2023 results on Nov 03, 2023
お知らせ • Sep 13India Glycols Limited Announces Cessation of Tejinder Paul Sharma as Head IMFL (Sales & Marketing)India Glycols Limited announced that Mr. Tejinder Paul Sharma, Head IMFL (Sales & Marketing) ceases to be a Senior Management Person of the Company on attaining superannuation with effect from close of business hours of 12th September, 2023.
Upcoming Dividend • Aug 29Upcoming dividend of ₹7.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 05 September 2023. Payment date: 12 October 2023. Payout ratio is a comfortable 19% but the company is not cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%).
お知らせ • Aug 18+ 1 more updateIndia Glycols Limited Announces Resignation of Dipankar Mukherjee as Head - Technical ServicesIndia Glycols Limited announced that Mr. Dipankar Mukherjee, Head - Technical Services, a senior management person, has tendered his resignation on account of personal reasons. The Company has accepted his resignation and relieved him from the service w.e.f. 12th August, 2023.
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹733, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 163% over the past three years.
Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: ₹16.52 (vs ₹8.91 in 1Q 2023)First quarter 2024 results: EPS: ₹16.52 (up from ₹8.91 in 1Q 2023). Revenue: ₹19.0b (up 135% from 1Q 2023). Net income: ₹511.4m (up 76% from 1Q 2023). Profit margin: 2.7% (down from 3.6% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 01India Glycols Limited to Report Q1, 2024 Results on Aug 07, 2023India Glycols Limited announced that they will report Q1, 2024 results on Aug 07, 2023
Board Change • Jul 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 7 highly experienced directors. Additional Whole Time Director Pragya Barwale was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • May 25Full year 2023 earnings released: EPS: ₹45.55 (vs ₹106 in FY 2022)Full year 2023 results: EPS: ₹45.55 (down from ₹106 in FY 2022). Revenue: ₹66.7b (up 132% from FY 2022). Net income: ₹1.25b (down 62% from FY 2022). Profit margin: 1.9% (down from 12% in FY 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 25India Glycols Limited Recommends Dividend for the Financial Year Ended 31 March, 2023India Glycols Limited Recommended a dividend of INR 7.50/- per equity share (@75%) of face value of INR 10/- each for the financial year ended 31st March, 2023 which, if confirmed/declared by the members at the ensuing Annual General Meeting ("AGM"), will be paid/dispatched within 30 days from the date of AGM.
お知らせ • May 19India Glycols Limited to Report Q4, 2023 Results on May 24, 2023India Glycols Limited announced that they will report Q4, 2023 results on May 24, 2023
Reported Earnings • Feb 10Third quarter 2023 earnings released: EPS: ₹16.16 (vs ₹7.75 in 3Q 2022)Third quarter 2023 results: EPS: ₹16.16 (up from ₹7.75 in 3Q 2022). Revenue: ₹5.54b (down 30% from 3Q 2022). Net income: ₹500.3m (up 108% from 3Q 2022). Profit margin: 9.0% (up from 3.0% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 27% per year.
お知らせ • Feb 02India Glycols Limited to Report Q3, 2023 Results on Feb 08, 2023India Glycols Limited announced that they will report Q3, 2023 results on Feb 08, 2023
お知らせ • Dec 24Gateway Distriparks Limited (NSEI:GATEWAY) completed the acquisition of 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited.Gateway Distriparks Limited (NSEI:GATEWAY) signed the Share Purchase Agreement to acquire 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited for INR 1.6 billion on October 31, 2022. The purchase consideration is payable in cash, which is subject to certain preclosing and post-closing adjustments in accordance with the terms of the SPA. India Glycols holds 42.31% stake and its nominee(s) and affiliate holds 6.61% in Kashipur Infrastructure. The process to acquire the remaining 0.08% shareholding from Fourcee Infrastructure Equipments Private Limited (in liquidation) has been initiated at the same per share price as finally paid for acquisition of the 99.92% shareholding. KIFTPL has earned a revenue of approximately INR 275.5 million and net worth of INR 677.6 million in FY 2021-22. The proposed transaction is subject to customary approvals, and other conditions precedent required to be fulfilled by KIFTPL and / or the Sellers. Board of Directors of India Glycols and Gateway Distriparks approved the Kashipur Infrastructure transaction. The transaction is expected within third quarter of FY 2022-23. Prasenjit Chakravarti, and Nitish Goel of Khaitan & Co acted as advisor to GDL In Its Acquisition Of Kashipur Infrastructure Gateway Distriparks Limited (NSEI:GATEWAY) completed the acquisition of 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited on December 23, 2022.
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹7.62 (vs ₹12.04 in 2Q 2022)Second quarter 2023 results: EPS: ₹7.62 (down from ₹12.04 in 2Q 2022). Revenue: ₹6.70b (down 14% from 2Q 2022). Net income: ₹235.8m (down 37% from 2Q 2022). Profit margin: 3.5% (down from 4.8% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹7.62 (vs ₹12.04 in 2Q 2022)Second quarter 2023 results: EPS: ₹7.62 (down from ₹12.04 in 2Q 2022). Revenue: ₹16.4b (up 110% from 2Q 2022). Net income: ₹235.8m (down 37% from 2Q 2022). Profit margin: 1.4% (down from 4.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 04India Glycols Limited to Report Q2, 2023 Results on Nov 10, 2022India Glycols Limited announced that they will report Q2, 2023 results on Nov 10, 2022
お知らせ • Nov 02Gateway Distriparks Limited (NSEI:GATEWAY) signed the Share Purchase Agreement to acquire 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited for INR 1.6 billion.Gateway Distriparks Limited (NSEI:GATEWAY) signed the Share Purchase Agreement to acquire 99.92% stake in Kashipur Infrastructure And Freight Terminal Private Limited from Apollo Logisolutions Limited, India Glycols Limited and Kashipur Holdings Limited for INR 1.6 billion on October 31, 2022. The purchase consideration is payable in cash, which is subject to certain preclosing and post-closing adjustments in accordance with the terms of the SPA. India Glycols holds 42.31% stake and its nominee(s) and affiliate holds 6.61% in Kashipur Infrastructure. The process to acquire the remaining 0.08% shareholding from Fourcee Infrastructure Equipments Private Limited (in liquidation) has been initiated at the same per share price as finally paid for acquisition of the 99.92% shareholding. KIFTPL has earned a revenue of approximately INR 275.5 million and net worth of INR 677.6 million in FY 2021-22. The proposed transaction is subject to customary approvals, and other conditions precedent required to be fulfilled by KIFTPL and / or the Sellers. Board of Directors of India Glycols and Gateway Distriparks approved the Kashipur Infrastructure transaction. The transaction is expected within third quarter of FY 2022-23. Prasenjit Chakravarti, and Nitish Goel of Khaitan & Co acted as advisor to GDL In Its Acquisition Of Kashipur Infrastructure
お知らせ • Sep 08India Glycols Limited Declares Dividend for the Financial Year 2021-22India Glycols Limited at it's AGM approved dividend of INR 7.50 per Equity share for the financial year 2021-22.
Upcoming Dividend • Aug 22Upcoming dividend of ₹7.50 per shareEligible shareholders must have bought the stock before 29 August 2022. Payment date: 07 October 2022. Payout ratio is a comfortable 15% but the company is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.7%).
お知らせ • Aug 13India Glycols Limited, Annual General Meeting, Sep 07, 2022India Glycols Limited, Annual General Meeting, Sep 07, 2022, at 11:00 Indian Standard Time. Agenda: To receive, consider and adopt the audited financial statements (including the consolidated financial statements) of the Company for the financial year ended 31st March, 2022, together with the Reports of the Board of Directors and Auditors thereon;to declare dividend of INR 7.50/- per Equity share for the financial year 2021-22;to appoint a Director in place of Shri Sudhir Agarwal (DIN: 08602216), who retires by rotation and being eligible, offers himself for re-appointment;and to consider other matters.
Reported Earnings • Aug 11First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: ₹8.14b (up 25% from 1Q 2022). Net income: ₹290.2m (down 86% from 1Q 2022). Profit margin: 3.6% (down from 31% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 53% per year whereas the company’s share price has increased by 56% per year.
お知らせ • Aug 03India Glycols Limited to Report Q1, 2023 Results on Aug 09, 2022India Glycols Limited announced that they will report Q1, 2023 results on Aug 09, 2022
Reported Earnings • May 30Full year 2022 earnings released: EPS: ₹106 (vs ₹35.27 in FY 2021)Full year 2022 results: EPS: ₹106 (up from ₹35.27 in FY 2021). Revenue: ₹28.7b (up 24% from FY 2021). Net income: ₹3.30b (up 202% from FY 2021). Profit margin: 12% (up from 4.7% in FY 2021). Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 49% per year.
お知らせ • May 27India Glycols Limited Recommends Dividend for the Financial Year Ended March 31, 2022India Glycols Limited at its board meeting held on May 26, 2022 recommended a dividend of INR 7.50 per equity share (@75%) of face value of INR 10 each for the financial year ended March 31, 2022 which, if confirmed/declared by the members at the upcoming Annual General Meeting, will be paid/dispatched within 30 days from the date of AGM.
お知らせ • May 20India Glycols Limited to Report Q4, 2022 Results on May 26, 2022India Glycols Limited announced that they will report Q4, 2022 results on May 26, 2022
Valuation Update With 7 Day Price Move • May 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹1,018, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 342% over the past three years.
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹1,126, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 335% over the past three years.
Reported Earnings • Feb 14Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹7.75 (down from ₹9.62 in 3Q 2021). Revenue: ₹17.7b (up 97% from 3Q 2021). Net income: ₹240.1m (down 20% from 3Q 2021). Profit margin: 1.4% (down from 3.3% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 05India Glycols Limited to Report Q3, 2022 Results on Feb 11, 2022India Glycols Limited announced that they will report Q3, 2022 results on Feb 11, 2022
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹926, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 218% over the past three years.
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹762, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 113% over the past three years.
Reported Earnings • Aug 11First quarter 2022 earnings released: EPS ₹64.99 (vs ₹1.38 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹6.51b (up 69% from 1Q 2021). Net income: ₹2.01b (up ₹1.97b from 1Q 2021). Profit margin: 31% (up from 1.1% in 1Q 2021).
Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improved over the past weekAfter last week's 39% share price gain to ₹747, the stock trades at a trailing P/E ratio of 21.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 88% over the past three years.
Reported Earnings • Jun 27Full year 2021 earnings released: EPS ₹35.27 (vs ₹37.03 in FY 2020)The company reported a mediocre full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹54.4b (up 56% from FY 2020). Net income: ₹1.09b (down 4.8% from FY 2020). Profit margin: 2.0% (down from 3.3% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹551, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 28% over the past three years.
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹492, the stock trades at a trailing P/E ratio of 19.4x, down from the previous P/E ratio of 23.1x. Average P/E is 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 9.2%.
Is New 90 Day High Low • Feb 25New 90-day high: ₹499The company is up 69% from its price of ₹295 on 27 November 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
お知らせ • Feb 19Clariant Chemicals Denies News on Buying Stake in India GlycolsReferring February 16, 2021 news, seeking clarification upon the recent news item which appeared on the Channel CNBC TV18 dated February 16, 2021 captioned 'Clariant Chemicals (India) Limited (BSE:506390) is planning to buy 51% stake in India Glycols Limited (BSE:500201)'. In this regard, Clariant Chemicals submit that Clariant Chemicals (India) Limited (hereinafter referred to as 'the Company') is not engaged in any discussions to acquire a stake, in India Glycols. The Company categorically states that the abovementioned news item is factually incorrect.
Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹9.62 (vs ₹8.59 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹18.3b (up 112% from 3Q 2020). Net income: ₹298.2m (up 12% from 3Q 2020). Profit margin: 1.6% (down from 3.1% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 06India Glycols Limited to Report Q3, 2021 Results on Feb 12, 2021India Glycols Limited announced that they will report Q3, 2021 results on Feb 12, 2021
Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹426, the stock is trading at a trailing P/E ratio of 17.5x, up from the previous P/E ratio of 14.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 7.4%.
Is New 90 Day High Low • Feb 02New 90-day high: ₹410The company is up 52% from its price of ₹269 on 04 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹372, the stock is trading at a trailing P/E ratio of 15.3x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 19x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 30%.
Is New 90 Day High Low • Dec 30New 90-day high: ₹314The company is up 12% from its price of ₹280 on 01 October 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.
お知らせ • Dec 23India Glycols Ltd. Appoints Rupark Sarswat as CEOIndia Glycols Limited announced the appointment of Shri Rupark Sarswat as Chief Executive Officer and Key Managerial Personnel of the Company, as approved by the Board of Directors of the Company at their meeting held on 6 November, 2020, is effective from 21 December, 2020.
Is New 90 Day High Low • Dec 04New 90-day high: ₹299The company is up 5.0% from its price of ₹285 on 04 September 2020. The Indian market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
お知らせ • Nov 07India Glycols Limited Appoints Rupark Sarswat as CEO, Effective on or Before December 18, 2020India Glycols Limited announced that at the board meeting held on November 6, 2020, it has approved appointment of Shri Rupark Sarswat as CEO and key managerial personnel of the company, on recommendation of the nomination and remuneration committee of the company. His joining date will be informed separately, which will be on or before December 18, 2020. He brings an experience of over 25 years in the specialty chemicals domain working in various roles in Business Management, Supply Chain & Operations etc. He is currently the Managing Director at Transpek-Silox Industries Private Limited which is a part of the Silox group of Belgium.
Reported Earnings • Nov 07Second quarter 2021 earnings released: EPS ₹8.58The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues were improved. Second quarter 2021 results: Revenue: ₹15.4b (up 81% from 2Q 2020). Net income: ₹265.5m (down 26% from 2Q 2020). Profit margin: 1.7% (down from 4.2% in 2Q 2020). The decrease in margin was driven by higher expenses.
Is New 90 Day High Low • Nov 04New 90-day low: ₹269The company is down 1.0% from its price of ₹272 on 06 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
お知らせ • Oct 31India Glycols Limited to Report Q2, 2021 Results on Nov 06, 2020India Glycols Limited announced that they will report Q2, 2021 results on Nov 06, 2020
お知らせ • Aug 07India Glycols Limited to Report Q1, 2021 Results on Aug 13, 2020India Glycols Limited announced that they will report Q1, 2021 results on Aug 13, 2020
お知らせ • Jun 18India Glycols Limited to Report Q4, 2020 Results on Jun 24, 2020India Glycols Limited announced that they will report Q4, 2020 results on Jun 24, 2020
